Appropriateness of gentamicin therapeutic drug monitoring at a Middle Eastern tertiary hospital setting: a retrospective evaluation and quality audit

References

• Al-Lanqawi, Y., Capps, P., Abdel-hamid, M., Abulmalek, K., Phillips, D., Matar, K., Sharma, P., & Thusu, A. (2007). Therapeutic drug monitoring of gentamicin: evaluation of five nomograms for initial dosing at Al-Amiri Hospital in Kuwait. Medical Principles and Practice, 16(5), 348–354. https://doi.org/10.1159/000104807
   PubMed Web of Science ®Google Scholar
• Al-Sulaiti, F. K., Nader, A., El-Mekaty, E., Elewa, H., Al-Badriyeh, D., El-Zubair, A., Saad, M. O., & Awaisu, A. (2020). Vancomycin therapeutic drug monitoring service quality indices and clinical effectiveness outcomes: A retrospective cohort and clinical audit. JACCP: Journal of the American College of Clinical Pharmacy, 3(4), 778–785. https://doi.org/10.1002/jac5.1223
   Google Scholar
• Al Za'abi, M., Al Muqbali, J., & Al-Waili, K. (2015). Sampling time and indications appropriateness for therapeutically monitored drugs at a teaching university hospital in Oman. Saudi Pharmaceutical Journal, 23(4), 458–462. https://doi.org/10.1016/j.jsps.2014.11.005
   PubMed Web of Science ®Google Scholar
• Batton, D. G., Barrington, K. J., & Wallman, C. (2006). Prevention and management of pain in the neonate: an update. Pediatrics, 118(5), 2231–2241. https://doi.org/10.1542/peds.2006-2277
   PubMed Web of Science ®Google Scholar
• Bauer, L. A. (2008). Applied clinical pharmacokinetics. McGraw Hill.
   Google Scholar
• Ben Romdhane, H., Ben Fredj, N., Chaabane, A., Ben Aicha, S., Chadly, Z., Ben Fadhel, N., Boughattas, N., & Aouam, K. (2019). Interest of therapeutic drug monitoring of aminoglycosides administered by a monodose regimen. Néphrologie & Thérapeutique, 15(2), 110–114. https://doi.org/10.1016/j.nephro.2018.08.004
   PubMed Web of Science ®Google Scholar
• Crcek, M., Zdovc, J., & Kerec Kos, M. (2019). A review of population pharmacokinetic models of gentamicin in paediatric patients. Journal of Clinical Pharmacy and Therapeutics, 44(5), 659–674. https://doi.org/10.1111/jcpt.12850
   PubMed Web of Science ®Google Scholar
• Crist, K. D., Nahata, M. C., & Ety, J. (1987). Positive impact of a therapeutic drug-monitoring program on total aminoglycoside dose and cost of hospitalization. Therapeutic Drug Monitoring, 9(3), 306–310. https://doi.org/10.1097/00007691-198709000-00010
   PubMed Web of Science ®Google Scholar
• Dandachi, I., Chaddad, A., Hanna, J., Matta, J., & Daoud, Z. (2019). Understanding the epidemiology of multi-drug resistant gram-negative bacilli in the Middle East using a one health approach. Frontiers in Microbiology, 10(1941). https://doi.org/10.3389/fmicb.2019.01941
   PubMedGoogle Scholar
• du Toit, M., Burger, J. R., Rakumakoe, D. M., & Rheeders, M. (2019). Standards of aminoglycoside therapeutic drug monitoring in a South African private hospital: perspectives and implications. Ghana Medical Journal, 53(1), 8–12. https://doi.org/10.4314/gmj.v53i1.2
   PubMedGoogle Scholar
• Flannigan, C., Kilpatrick, S., Redpath, J., & Hogan, M. (2010). 481 Can a gentamicin specific chart reduce neonatal medication errors? Pediatric Research, 68(1), 245–246. https://doi.org/10.1203/00006450-201011001-00481
   Google Scholar
• Gilbert, D. N., Eliopoulos, G. M., Chambers, H. F., Saag, M. S., & Pavia, A. (2019). The Sanford guide to antimicrobial therapy 2019. Antimicrobial Therapy, Inc.
   Google Scholar
• Hartman, S. J. F., Brüggemann, R. J., Orriëns, L., Dia, N., Schreuder, M. F., & de Wildt, S. N. (2020). Pharmacokinetics and target attainment of antibiotics in critically ill children: a systematic review of current literature. Clinical Pharmacokinetics, 59(2), 173–205. https://doi.org/10.1007/s40262-019-00813-w
   PubMed Web of Science ®Google Scholar
• HMC: Hamad Medical Corporation. (2006–2020). Antimicrobial prescribing policy. Hamad Medical Corporation.
   Google Scholar
• HMC: Hamad Medical Corporation. (2016). Annual report (Annual report). Hamad Medical Corporation.
   Google Scholar
• Ho, K. K., Thiessen, J. J., Bryson, S. M., Greenberg, M. L., Einarson, T. R., & Leson, C. L. (1994). Challenges in comparing treatment outcome from a prospective with that of a retrospective study: assessing the merit of gentamicin therapeutic drug monitoring in pediatric oncology. Therapeutic Drug Monitoring, 16(3), 238–247. https://doi.org/10.1097/00007691-199406000-00003
   PubMed Web of Science ®Google Scholar
• Hodiamont, C. J., Janssen, J. M., de Jong, M. D., Mathôt, R. A., Juffermans, N. P., & van Hest, R. M. (2017). Therapeutic drug monitoring of gentamicin peak concentrations in critically ill patients. Therapeutic Drug Monitoring, 39(5), 522–530. https://doi.org/10.1097/FTD.0000000000000432
   PubMed Web of Science ®Google Scholar
• Ismail, R., Sarriff, A., & Abdul Rahman, A. F. (1990). Therapeutic drug monitoring for gentamicin in Hospital Universiti Sains Malaysia. Medical Journal of Malaysia, 45(1), 57–64.
   PubMedGoogle Scholar
• Kadambari, S., Heath, P. T., Sharland, M., Lewis, S., Nichols, A., & Turner, M. A. (2011). Variation in gentamicin and vancomycin dosage and monitoring in UK neonatal units. Journal of Antimicrobial Chemotherapy, 66(11), 2647–2650. https://doi.org/10.1093/jac/dkr351
   PubMed Web of Science ®Google Scholar
• Kheir, N., Awaisu, A., Gad, H., Elazzazy, S., Jibril, F., & Gajam, M. (2015). Clinical pharmacokinetics: perceptions of hospital pharmacists in Qatar about how it was taught and how it is applied. International Journal of Clinical Pharmacy, 37(6), 1180–1187. https://doi.org/10.1007/s11096-015-0183-3
   PubMed Web of Science ®Google Scholar
• Krzyżaniak, N., Pawłowska, I., & Bajorek, B. (2016). Review of drug utilization patterns in NICUs worldwide. Journal of Clinical Pharmacy and Therapeutics, 41(6), 612–620. https://doi.org/10.1111/jcpt.12440
   PubMed Web of Science ®Google Scholar
• Lee, J., Yoon, S., Shin, D., Han, H., An, H., Lee, J., Lim, K. S., Yu, K. S., & Lee, H. (2014). Predictive performance of gentamicin dosing nomograms. Drug Design, Development and Therapy, 8, 1097–1106. https://doi.org/10.2147/DDDT.S66981
   PubMed Web of Science ®Google Scholar
• Lim, W. X. S., Chua, W. B. B., Chua, J. M., Lee, Q., Chan, J. W., Sultana, R., & Poh, B. H. (2020). A retrospective review of the efficiency of first-dose therapeutic drug monitoring of gentamicin, amikacin, and vancomycin in the pediatric population. The Journal of Clinical Pharmacology, 60(1), 7–15. https://doi.org/10.1002/jcph.1509
   PubMed Web of Science ®Google Scholar
• Mijović, G., Čizmović, L., Vuković, M. N., Stamatović, S., & Lopičić, M. (2020). Antibiotic consumption in hospitals and resistance rate of Klebsiella pneumoniae and Escherichia coli in Montenegro. Acta Clinica Croatica, 59(3), 469–479. https://doi.org/10.20471/acc.2020.59.03.11
   PubMed Web of Science ®Google Scholar
• Ohnishi, K., & Mikamo, H. (2013). Results of a questionnaire survey on the use of gentamicin sulfate injection. Kansenshogaku Zasshi, 87(3), 357–367. https://doi.org/10.11150/kansenshogakuzasshi.87.357
   PubMedGoogle Scholar
• Reynolds, L. F., Mailman, T. L., & McMillan, D. D. (2012). Gentamicin in neonates at risk for sepsis – Peak serum concentrations are not necessary. Paediatrics & Child Health, 17(6), 310–312. https://pubmed.ncbi.nlm.nih.gov/23730168
   PubMed Web of Science ®Google Scholar
• Roberts, J. A., Norris, R., Paterson, D. L., & Martin, J. H. (2012). Therapeutic drug monitoring of antimicrobials. British Journal of Clinical Pharmacology, 73(1), 27–36. https://doi.org/10.1111/j.1365-2125.2011.04080.x
   PubMed Web of Science ®Google Scholar
• Saddi, V., Preddy, J., Dalton, S., Connors, J., & Patterson, S. (2017). Variation in gentamicin dosing and monitoring in pediatric units across New South Wales. Pediatric Quality & Safety, 2(2), e015. https://doi.org/10.1097/pq9.0000000000000015
   PubMedGoogle Scholar
• Singu, B. S., Mubita, M., Thikukutu, M. M., Mufenda, J. K., McKenzie, S. B., & Verbeeck, R. K. (2018). Monitoring of gentamicin serum concentrations in obstetrics and gynaecology patients in Namibia. International Journal of Clinical Pharmacy, 40(3), 520–525. https://doi.org/10.1007/s11096-018-0626-8
   PubMed Web of Science ®Google Scholar
• Sweileh, W. M. (2009). A prospective comparative study of gentamicin- and amikacin-induced nephrotoxicity in patients with normal baseline renal function. Fundamental & Clinical Pharmacology, 23(4), 515–520. https://doi.org/10.1111/j.1472-8206.2009.00702.x
   PubMed Web of Science ®Google Scholar
• Valitalo, P. A., van den Anker, J. N., Allegaert, K., de Cock, R. F., de Hoog, M., Simons, S. H., Mouton, J. W., & Knibbe, C. A. (2015). Novel model-based dosing guidelines for gentamicin and tobramycin in preterm and term neonates. Journal of Antimicrobial Chemotherapy, 70(7), 2074–2077. https://doi.org/10.1093/jac/dkv052
   PubMed Web of Science ®Google Scholar